Back to News
Market Impact: 0.08
Amino Minder Brings Real Pharmacokinetic Modeling to Peptide and GLP-1 Tracking, Now Live on the Web -- Android App Coming Soon
Source: PR Newswire
Product LaunchesHealthcare & BiotechTechnology & Innovation
Baya Lobo LLC launched Amino Minder, a web-based tracker for peptide and GLP-1 use that extends beyond dose logging to estimate plasma levels over time and model downstream hormone cascades for GH-secretagogue stacks. The announcement provides no revenue, user-growth, pricing, clinical-validation, or financial guidance metrics, limiting expected market relevance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- CNBC Daily Open: Sanctions, strikes and the road to $100 oil
- Nvidia Earnings Blow Everyone Away
- China's EV makers shift gears to focus on humanoids as car market slows
- Apple's $2000+ iPhone, Oil Gain Stokes Inflation Fear | Bloomberg Businessweek Daily 9/8/2026
- Jensen Huang's AI Capex Pulse Check
- Dell (DELL) Q2 2027 Earnings Call Transcript